Codexis Inc gains on plan to lay off 25% of workforce
** Enzyme engineering company Codexis Inc's CDXS.O shares
up 4.61% at $3.63 after market
** Company plans to lay off 25% of its workforce by Sept. 30
** Codexis reiterates 2023 product revenue outlook between
$30 mln-$35 mln
** Company expects its pharmaceutical manufacturing business
to return to growth in 2024
** As of last close, Codexis shares down 25.5% YTD
(Reporting by Pritam Biswas in Bengaluru)
((Pritam.Biswas@thomsonreuters.com))
Recent news on Codexis
See all newsCodexis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Codexis Q2 net loss narrows, helped by lower operating expenses
Codexis, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor